OBJECTIVE -To determine whether the high prevalence of hepatitis B surface antigen (HBsAg) carriage in our population can explain the previous observation of an association between increased maternal serum ferritin concentration and gestational diabetes in Hong Kong Chinese women.
I
ncreased serum ferritin concentration, which is associated with insulin resistance and diabetes in the general population (1, 2) , has also been recently reported in gestational diabetes (3, 4) .
This was at variance with evidence of depletion of maternal/fetal iron stores in earlier studies (5) (6) (7) (8) , and the explanation remains unclear. Increased serum ferritin in gestational diabetes could represent an acute phase response, as in the case of preterm birth and infection (9 -11) and preeclampsia (12, 13) . Another possibility is iron overload, as in transfusion-treated homozygous ␤-thalassemia (14) and hereditary hemochromatosis (15) , which induces liver damage and diabetes. However, the latter conditions were absent and could not have accounted for the observation in the aforementioned studies (3, 4) .
In nonpregnant subjects, chronic hepatitis C virus (HCV) infection is associated with iron overload (16, 17) and increased risk of type 2 diabetes (18 -24) . In Hong Kong, chronic HCV infection is of minor epidemiological significance (25) , and HCV coinfection was found in only 0.7% of subjects with chronic hepatitis B virus (HBV) infection (26) . However, 10% of our obstetric population are asymptomatic carriers of the hepatitis B surface antigen (HBsAg) (27) , most of whom had contracted the infection vertically (28) . Unlike chronic HCV infection, the influence of HBsAg carrier status on glucose tolerance is unclear, especially in the pregnant population. To determine whether maternal HBsAg carrier status could account for the increased iron parameters in gestational diabetes in our population, a retrospective cohort study was performed.
RESEARCH DESIGN AND METHODS -Our hospital is a government-funded regional hospital with 5,000 deliveries per annum and caters to the residents of Hong Kong, of whom Ͼ90% are ethnic Chinese. A multivitamin preparation containing 29 mg of elemental iron was offered to all patients, but patient compliance was not monitored. At the booking antenatal visit, routine screening of HBsAg status (enzymelinked immunosorbent assay) and hemoglobin concentration and mean corpuscular volume for carrier status of the thalassemia traits were performed. Hemo-globin measurement was repeated at 28 -30 weeks. Anemia (hemoglobin level Ͻ10 g/dl) was investigated and treated accordingly.
Women at high risk for gestational diabetes, including those of advanced age (Ն35 years), relevant obstetric and family history, prepregnant weight Ն75 kg, and recurrent/significant glycosuria, underwent a 75-g oral glucose tolerance test (OGTT) interpreted by World Health Organization criteria. Gestational diabetes was diagnosed if the 2-h OGTT glucose value was Ն8.0 mmol/l (29) . Low-risk women had random blood glucose testing at 28 -30 weeks. Those with glucose levels Ͼ5.8 mmol/l if Ͻ2 h postprandial, and Ͼ5.0 mmol/l if Ͼ2 h postprandial, also underwent the 75-g OGTT. The diagnosis and management of gestational diabetes have been previously described (30) .
In an earlier prospective study, the relationship between maternal first trimester hemoglobin and development of gestational diabetes in the third trimester has been examined after excluding women with late antenatal booking, preexisting anemia or hemoglobinopathies, gestational diabetes diagnosed before 28 weeks gestation, and multifetal pregnancy (30) . Maternal iron status was examined at 28 -30 weeks with the repeat hemoglobin estimation. The serum was aliquoted and stored for the batch assay of serum ferritin (microparticle enzyme immunoassay, IMx system; Abbott Laboratories, Abbott Park, IL) and serum iron and transferrin (measured as the total iron binding capacity with the calorimetric method) (Sigma, St. Louis, MO). Transferrin saturation was calculated as serum iron divided by the total iron binding capacity. Those who delivered elsewhere were excluded from the analysis.
For the present study, the same cohort, including women delivered in other hospitals, were reviewed to determine the maternal HBsAg status. Maternal demographics, including the incidence of advanced age (Ն35 years) and increased BMI (Ͼ25 kg/m 2 ), the prevalence of OGTT and gestational diabetes, and parameters of maternal iron status, were compared between the HBsAg-positive and -negative groups. The nondiabetic HBsAg-negative group was used as the reference group to generate the 25th, 50th, and 75th percentile values for serum ferritin and iron concentrations and transferrin saturation. A high value in any of these parameters is defined as a value in the highest quartile, and the prevalence of high values for each of these parameters was compared between the HBsAgpositive and -negative groups and in relation to gestational diabetes status.
Statistical analysis was performed using a commercial computer package (SPSS for Windows; SPSS, Chicago, IL). Categorical variables were compared with the 2 test, and odds ratios (ORs) with 95% CIs were generated. Continuous variables were expressed as means Ϯ SD and tested by the t test for initial comparison between the HBsAg-positive and -negative groups. Further analysis with respect to gestational diabetes and HBsAg status was performed with one-way ANOVA, with Duncan's test for post hoc analysis set at the 5% level, using the nondiabetic HBsAg-negative group as the reference group. Multiple logistic regression analysis was used to determine the role of HBsAg status compared with high serum ferritin in the development of gestational diabetes using both forward and backward stepwise logistic regression analysis after adjusting for age Ն35 years, BMI Ͼ25 kg/m 2 , poor socioeconomic status (monthly income ϽHK$10,000), multiparity status, and the presence of significant obstetric, family, and past history.
RESULTS -The cohort consisted of 767 women, including 37 women who delivered elsewhere. The HBsAg-positive women were significantly older and had a higher prevalence of advanced maternal age, but the differences in anthropometric parameters did not reach statistical significance (Table 1) . They had more OGTTs performed, and the 2-h glucose value was significantly higher due to a higher prevalence (48.9 vs. 20.9%, P Ͻ 0.0001) of abnormal results. On multiple logistic regression analysis, the only significant factors for gestational diabetes were maternal On further analysis with respect to gestational diabetes and HBsAg status combined, we found a significant difference in the mean age and prevalence of advanced age (Ն35 years) among the four groups ( Table 2 ). The gestational diabetes groups had significantly higher mean age, and there was an inverse correlation between prevalence of advanced age with prevalence of gestational diabetes (Spearman's correlation, P Ͻ 0.0001). Although there was no significant difference in the prevalence of multiparity, or mean weight or height, there was a significant difference in the mean BMI and prevalence of overweight (BMI Ͼ25 kg/m 2 ), but in no group was the BMI outstandingly high. Although there was a significant difference in gestational age, there was no difference in the mean birth weight. No significant difference was found among the four groups in the prevalence of poor socioeconomic status (45.5, 37.8, 45.2, and 33.2%, respectively), significant past obstetric history (22.7, 13.3, 18.6, and 15.2%, respectively), or significant family or medical history (21.1, 18.6, 22.9, and 22.2%, respectively).
While the 0-and 2-h values for the antenatal OGTT were significantly higher in the gestational diabetes groups, as expected, there was no difference in either the 0-or 2-h values of the postnatal OGTT (performed 6 weeks postpartum in women with gestational diabetes) between the HBsAg-positive and -negative groups (Table 3) . Although the prevalence of abnormal postnatal OGTT values was higher in the HBsAg-negative women, this difference failed to reach statistical significance. The diabetic HBsAgpositive women had a significantly increased prevalence of high ferritin compared with diabetic HBsAg-negative women (OR 2.73, 95% CI 1.05-7.09) and with nondiabetic HBsAg-negative women (3.29, 1.48 -7.32). Similarly, the diabetic HBsAg-positive women had a significantly increased prevalence of high transferrin saturation compared with the nondiabetic HBsAg-positive women (3.13, 1.02-9.71). The distribution of serum ferritin concentration in the four groups is shown in Fig. 1 .
To determine the primacy of the association between maternal HBsAg carrier status and high ferritin status with the development of gestational diabetes, both forward and backward stepwise multiple logistic regression analysis were performed, taking into account multiparity, age Ն35 years, BMI Ͼ25 kg/m 2 , past obstetric, medical, and family history, and poor socioeconomic status. In both analyses, only maternal age (relative risk 3.66, 95% CI 2.11-6.34 and 3.59, 2.08 -6.21, respectively) and HBsAg carrier status (3.51, 1.83-6.73 and 3.46, 1.80 -6.62, respectively) remained significant independent factors.
CONCLUSIONS -Hepatic damage secondary to chronic HCV infection leads to type 2 diabetes (18 -24) . Pregnancy also induces hepatic insulin resistance because significant changes in the early steps of insulin signal transduction in the liver occur without change in the insulin receptor concentration in pregnant rats at day 20 of gestation (31) . Nevertheless, the combination of chronic hepatocellular damage with pregnancy on the risk of gestational diabetes has not yet been examined.
In this study, the prevalence of HBsAg carriage was 9.1%, which is similar to the 10% previously reported (27) . We found a threefold higher prevalence (32.9%) of gestational diabetes among HBsAg carriers, whereas the 11.0% prevalence of gestational diabetes among the HBsAg- Data are means Ϯ SD (one-way ANOVA) or % ( 2 test). *P Ͻ 0.0001; †P Ͻ 0.05 compared with the other three groups (Duncan's test); ‡P Ͻ 0.05 compared with nondiabetic groups (Duncan's test); §P Ͻ 0.0001; P ϭ 0.024; ¶P ϭ 0.023; #P ϭ 0.041.
negative patients was similar to the 13.7% prevalence previously reported (32) . As the prevalence of diabetes in the nonpregnant subjects with chronic HBV infection is between 2.5% to 12.0% (19 -24) , it is likely that the superimposed effect of pregnancy was responsible for the increased prevalence of gestational diabetes in the HBsAg-positive women.
Maternal HBsAg carrier status could explain the association between increased maternal ferritin concentration and gestational diabetes (3, 4) , as the prevalence of high ferritin concentration was increased in these women compared with the HBsAg-negative women, irrespective of the latter group's glucose tolerance status. This is similar to the finding of increased serum iron and ferritin in subjects with chronic HBV infection attributed to hepatocellular release secondary to tissue necrosis (16, 17) .
Serum ferritin concentration could also have reflected the activity of the chronic inflammatory state, which induces insulin resistance and endothelial dysfunction (33) . The HBsAg-positive women with gestational diabetes also had significantly increased prevalence of high transferrin saturation. Excess iron can affect insulin synthesis and secretion and enhance oxidation of lipids, especially free fatty acids, the increased oxidation of which decreases glucose utilization in muscles and increases gluconeogenesis in liver, leading to liver-mediated insulin resistance (34) . Iron accumulation in hepatocytes also impairs hepatic insulin extraction (35) . However, the exclusion of increased serum ferritin as an independent factor for gestational diabetes in this study suggests that chronic HBV infection plays the primary role.
The HBsAg-positive group had a significantly higher prevalence of women aged Ն35 years, and the development of gestational diabetes was associated with increased age and decreased height, which are known risk factors for gestational diabetes in the overall obstetric population, but there was no difference in these factors between the HBsAg-positive and -negative women with gestational diabetes. Aging increases hepatic insulin resistance, as is seen in 20-month-old rats, which demonstrated a significant decrease in insulin signal transduction in the liver in the absence of any difference in insulin receptor concentration when compared with 2-month-old rats (31, 36) . Our finding that advanced age is an independent factor for gestational diabetes was similar to the finding of age as a risk factor for type 2 diabetes in HCV-infected subjects (22) (23) (24) and suggests that aging aggravates the effect of chronic HBV infection in pregnancy.
As a retrospective study, we could not determine the presence or degree of hepatocellular damage in relation to the development of gestational diabetes. Nevertheless, our finding suggests that HBsAg carrier status aggravates pregnancy-induced hepatic insulin resistance leading to gestational diabetes in susceptible individuals because there was no increased prevalence of postnatal abnormal glucose tolerance, and it could account for the increased maternal serum ferritin concentration associated with gestational diabetes in our population (3, 4) . In populations with a low prevalence of HBV infection, this association may not be demonstrable. The role of HBsAg carrier status as a risk factor for gestational diabetes and diabetes should be explored further in the at-risk populations of the developing world.
